DRKS00006281已完成不适用
A Prospective Study of the Performance of the Bard® LifeStent® Solo Vascular Stent System (REALITY2) - REALITY2
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 31
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 21 Years 至 one（—）
- 性别
- All
入选标准
- •1. The subject or legal representative has been informed of the nature of the evaluation, agrees to its provisions, and has signed the informed consent form (ICF). 2. Subject agrees to comply with the protocol-mandated follow-up procedures and visits. 3. The subject is 21 years old. 4. Female subjects of childbearing potential must have a negative urine or serum pregnancy test within seven days prior to index procedure. Female subjects who are surgically sterile or post-menopausal are exempt from having a pregnancy test. 5. The subject has lifestyle-limiting claudication or minor tissue loss defined as: Rutherford Category 2-5 (moderate claudication to minor tissue loss). 6. The target lesion(s) has angiographic evidence of stenosis or restenosis 50% or occlusion of the SFA and/or popliteal artery (by visual estimate) and is amenable to PTA and stenting. 7. There is angiographic evidence of at least one vessel runoff to the foot (at the level of the malleolus).
排除标准
- •1. The subject is unable or unwilling to provide informed consent or is unable or unwilling to comply with the study follow-up procedure and visits. 2. The subject has claudication or critical limb ischemia described as Rutherford Category 0 (asymptomatic), 1 ( mild claudication), or 6 (major tissue loss). 3. The subject has a known contraindication (including allergic reaction) or sensitivity to antiplatelet/anticoagulant medications, nickel, titanium or tantalum. 4. The subject has a known sensitivity to contrast media that is not amenable to pretreatment with steroids or/and antihistamines. 5. The subject has a history of bleeding diatheses or coagulopathy. 6. The subject has concomitant renal failure with a creatinine of >2.5 mg/dL. 7. The subject has concomitant hepatic insufficiency, thrombophlebitis, uremia, systemic lupus erythematosus (SLE), or deep vein thrombosis (DVT) at the time of the study procedure. 8. The subject is receiving dialysis or immunosuppressive therapy. 9. The subject is participating in an investigational drug or another investigational device study. 10. The subject has another medical condition, which, in the opinion of the investigator, may cause him/her to be non-compliant with the protocol, confound the data interpretation, or is associated with limited life expectancy of less than two years. 11. The subject has extensive peripheral vascular disease, which, in the opinion of the investigator, precludes safe insertion of an introducer sheath. 12. The target lesion(s) is located within an aneurysm or associated with an aneurysm in the vessel segment either proximal or distal to the target lesion(s). 13. The subject has angiographic evidence of poor inflow, which would be deemed inadequate to support a vascular bypass graft. 14. The subject is diagnosed with septicemia at the time of the study procedure. 15. Patients with a stent previously implanted into the target vessel. 16. Lesions requiring the use of more than one investigational stent. 17. Bilateral disease in the native SFA and/or proximal popliteal artery where both limbs meet the inclusion/exclusion criteria and it is planned to treat both limbs within 30 days.
研究者
相似试验
已完成
不适用
A Prospective Study of the Performance of the Bard® LifeStent® 5F Vascular Stent SystemI70.2Atherosclerosis of arteries of extremitiesDRKS00011210Bard Peripheral Vascular, Inc.30
尚未招募
不适用
Pivotal trial to evaluate an Artificial intelligence (AI) diabetic retinopathy grading classifier in the New Zealand population undergoing regular screening for diabetic retinopathy.Diabetic retinopathyMetabolic and Endocrine - DiabetesEye - Diseases / disorders of the eyeDiabetesACTRN12620000488909Dr David Squirrell1,000
尚未招募
不适用
An Investigation to Evaluate the Performance of the Cepheid Xpert® HIV-1 VL XC TestHIV/AIDSPACTR201908919241847Cepheid800
已完成
不适用
Prospective study to investigate the performance of cytokine removal of polymethyl methacrylate hemofilters with two different membrane surface areaSevere sepsis, Septic shockJPRN-UMIN000012164Department of Emergency and Critical Care Medicine, Chiba University, Graduate School of Medicine20
已完成
不适用
An investigation into the performance of the pacing mode AA1R (R) with respect to the percentage ventricular pacing and the evolution of atrial fibrillation when compared to the mode DDD (R) in patients with Sick Sinus Syndrome (SAFE PACE)Sick Sinus SyndromeISRCTN22375710Record Provided by the NHSTCT Register - 2006 Update - Department of Health100